[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@dadbodfamilyguy](/creator/twitter/dadbodfamilyguy) "@vulturetrades Buy $CRBU and hold it for a long time . 36+mos . Do some research buy some other of the great $XBI names $CRSP . $BEAM . $NTLA $PRME .$EDIT . So many great names"  [@dadbodfamilyguy](/creator/x/dadbodfamilyguy) on [X](/post/tweet/1947119016658551156) 2025-07-21 02:18:43 UTC XX followers, XXX engagements "$CRBU do your own Due Diligence. Not financial advice Heres my take built in equal to or better than Yescartas overall response and cure rates ($1.5b 2023/2024 revenue estimates for Yescarta and that is autologous) CRBU is allogenic with a much (way) bigger addressable market if CRBU can generate 3x Yescarta (probably easily by 2029) then thats a blockbuster at $4.5b revenue per year and at a 3x to 5x multiple thats $13.5b to $22.5b market cap in 2029 NPV today (2025) is $11.3B to $18.9b know what you own . This is way way undervalued . And check out so many other good threads @Rocro33"  [@dadbodfamilyguy](/creator/x/dadbodfamilyguy) on [X](/post/tweet/1947690226580918361) 2025-07-22 16:08:31 UTC XX followers, XXX engagements "@BoujeeFinances $XBI genomics stocks . I like $CRBU but there are so many great ones .$PRME $NTLA $CRSP $BEAM . These are the future"  [@dadbodfamilyguy](/creator/x/dadbodfamilyguy) on [X](/post/tweet/1944991699815518414) 2025-07-15 05:25:32 UTC XX followers, 1841 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@dadbodfamilyguy
"@vulturetrades Buy $CRBU and hold it for a long time . 36+mos . Do some research buy some other of the great $XBI names $CRSP . $BEAM . $NTLA $PRME .$EDIT . So many great names" @dadbodfamilyguy on X 2025-07-21 02:18:43 UTC XX followers, XXX engagements
"$CRBU do your own Due Diligence. Not financial advice Heres my take built in equal to or better than Yescartas overall response and cure rates ($1.5b 2023/2024 revenue estimates for Yescarta and that is autologous) CRBU is allogenic with a much (way) bigger addressable market if CRBU can generate 3x Yescarta (probably easily by 2029) then thats a blockbuster at $4.5b revenue per year and at a 3x to 5x multiple thats $13.5b to $22.5b market cap in 2029 NPV today (2025) is $11.3B to $18.9b know what you own . This is way way undervalued . And check out so many other good threads @Rocro33" @dadbodfamilyguy on X 2025-07-22 16:08:31 UTC XX followers, XXX engagements
"@BoujeeFinances $XBI genomics stocks . I like $CRBU but there are so many great ones .$PRME $NTLA $CRSP $BEAM . These are the future" @dadbodfamilyguy on X 2025-07-15 05:25:32 UTC XX followers, 1841 engagements
/creator/twitter::1459889561459474436/posts